LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation
نویسندگان
چکیده
Abstract Parkinson’s disease is characterized by the progressive degeneration of dopaminergic neurons within substantia nigra pars compacta and presence protein aggregates in surviving neurons. The LRRK2 G2019S mutation one major determinants familial cases leads to late-onset with pleomorphic pathology, including α-synuclein accumulation deposition inclusions. We demonstrated that phosphorylates N-ethylmaleimide sensitive factor (NSF). observed containing NSF basal ganglia specimens from patients carrying variant, cellular animal models expressing variant. found kinase activity induces toxic aggregates. Of note, induction autophagy cleared aggregation rescued motor cognitive impairment aged hG2019S bacterial artificial chromosome (BAC) mice. suggest pathological phosphorylation impacts on biochemical properties, thus causing formation cytotoxic
منابع مشابه
Clinical heterogeneity of the LRRK2 G2019S mutation.
BACKGROUND Several pathogenic mutations have been reported in the leucine-rich repeat kinase 2 gene (LRRK2) that cause parkinsonism. The "common" LRRK2 G2019S kinase domain substitution has been reported to account for approximately 5% of familial and 1% of sporadic Parkinson disease. OBJECTIVE To observe the clinical heterogeneity presented by LRRK2 kinase mutation carriers. DESIGN, SETTIN...
متن کاملLRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
In response to brain injury, microglia rapidly extend processes that isolate lesion sites and protect the brain from further injury. Here we report that microglia carrying a pathogenic mutation in the Parkinson's disease (PD)-associated gene, G2019S-LRRK2 (GS-Tg microglia), show retarded ADP-induced motility and delayed isolation of injury, compared with non-Tg microglia. Conversely, LRRK2 knoc...
متن کاملLRRK2 kinase activity modulates presynaptic vesicle release
Mutations in Leucine-rich repeat kinase 2 (LRRK2) are the single most common cause of inherited Parkinson ́s disease (PD). Little is known about its involvement in the pathogenesis of PD mainly due to the lack of knowledge about the physiological role of LRRK2. Our previous results suggest that LRRK2 acts as a scaffold within the presynaptic bouton and that it is involved in neurotransmitter rel...
متن کاملAnalysis of the LRRK2 G2019S mutation in Alzheimer Disease.
Comment. Possessing an APOE ε4 allele is the most important genetic risk factor yet identified for sporadic AD and also significantly lowers onset age. It is therefore striking that despite their young age at onset, only 2 of our 10 biparietal patients were ε4-positive. While we believe that a lack of association between biparietal AD (or posterior cortical atrophy AD) and APOE ε4 genotype has ...
متن کاملSex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
Objective To evaluate sex differences and the relative effect of G2019S LRRK2 mutations in Parkinson's disease (PD). Methods 530 LRRK2 PD carriers and 759 noncarrier PD (idiopathic, IPD) evaluated as part of the Fox Foundation (MJFF) Consortium were included. All participants completed a study visit including information on clinical features, treatment, examination, and motor and nonmotor que...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Brain
سال: 2021
ISSN: ['1460-2156', '0006-8950']
DOI: https://doi.org/10.1093/brain/awab073